Taken together with previous literature, our results provide evidence that astrocytes may contribute to cerebrovascular and synaptic dysfunction at an early stage within AD progression through altered ICAM-1 and CXCL1 secretion in response to extracellular Aβ. The gene discussed is CXCL1; the disease is Alzheimer disease.